As previously described, the genetic polymorphisms in PNPLA3 C > G, TM6SF2 C > T, MBOAT7 C > T, and GCKR C > T genes are predisposed to NAFLD progression and HCC development [212]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.